[go: up one dir, main page]

AUPP032097A0 - Improved labelled diagnostic compositions and methods of their use - Google Patents

Improved labelled diagnostic compositions and methods of their use

Info

Publication number
AUPP032097A0
AUPP032097A0 AUPP0320A AUPP032097A AUPP032097A0 AU PP032097 A0 AUPP032097 A0 AU PP032097A0 AU PP0320 A AUPP0320 A AU PP0320A AU PP032097 A AUPP032097 A AU PP032097A AU PP032097 A0 AUPP032097 A0 AU PP032097A0
Authority
AU
Australia
Prior art keywords
methods
improved
diagnostic compositions
labelled diagnostic
labelled
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AUPP0320A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Peptide Delivery Systems Pty Ltd
Original Assignee
Peptide Delivery Systems Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Peptide Delivery Systems Pty Ltd filed Critical Peptide Delivery Systems Pty Ltd
Priority to AUPP0320A priority Critical patent/AUPP032097A0/en
Publication of AUPP032097A0 publication Critical patent/AUPP032097A0/en
Priority to AU11358/99A priority patent/AU1135899A/en
Priority to PCT/AU1998/000939 priority patent/WO1999024079A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
    • A61K49/1806—Suspensions, emulsions, colloids, dispersions
    • A61K49/1815—Suspensions, emulsions, colloids, dispersions compo-inhalant, e.g. breath tests
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
    • A61K49/1806—Suspensions, emulsions, colloids, dispersions
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Dispersion Chemistry (AREA)
  • Pathology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Cell Biology (AREA)
  • Radiology & Medical Imaging (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AUPP0320A 1997-11-11 1997-11-11 Improved labelled diagnostic compositions and methods of their use Abandoned AUPP032097A0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
AUPP0320A AUPP032097A0 (en) 1997-11-11 1997-11-11 Improved labelled diagnostic compositions and methods of their use
AU11358/99A AU1135899A (en) 1997-11-11 1998-11-11 Improved labelled diagnostic compositions and methods of their use
PCT/AU1998/000939 WO1999024079A1 (en) 1997-11-11 1998-11-11 Improved labelled diagnostic compositions and methods of their use

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPP0320A AUPP032097A0 (en) 1997-11-11 1997-11-11 Improved labelled diagnostic compositions and methods of their use

Publications (1)

Publication Number Publication Date
AUPP032097A0 true AUPP032097A0 (en) 1997-12-04

Family

ID=3804600

Family Applications (1)

Application Number Title Priority Date Filing Date
AUPP0320A Abandoned AUPP032097A0 (en) 1997-11-11 1997-11-11 Improved labelled diagnostic compositions and methods of their use

Country Status (2)

Country Link
AU (1) AUPP032097A0 (en)
WO (1) WO1999024079A1 (en)

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4310505A (en) * 1979-11-08 1982-01-12 California Institute Of Technology Lipid vesicles bearing carbohydrate surfaces as lymphatic directed vehicles for therapeutic and diagnostic substances
US4430321A (en) * 1982-01-15 1984-02-07 Merck Frosst Canada Inc. 6-Bromocholesterol derivatives
US4676974A (en) * 1984-05-17 1987-06-30 The Regents Of The University Of California Breath test for pancreatic exocrine function
CA1267840A (en) * 1984-11-23 1990-04-17 Cary Arnet Presant Method of targeting tumors in humans
US4753788A (en) * 1985-01-31 1988-06-28 Vestar Research Inc. Method for preparing small vesicles using microemulsification
JPS61204137A (en) * 1985-03-06 1986-09-10 Yutaka Mizushima radioactive contrast agent
SE456136B (en) * 1985-06-17 1988-09-12 Oncholab Ab PROCEDURE FOR THE PREPARATION OF A LIPOPHILIC BIOLOGY ACTIVE SUBSTANCE BASED BEARING BASIS OF RECONSTITUTED LDL (Layer Density Lipoprotein)
US4938947A (en) * 1985-11-01 1990-07-03 Centre National De La Recherche Scientifique (Cnrs) Aerosol composition for in vivo imaging
US4933157A (en) * 1988-06-27 1990-06-12 The University Of Michigan Radioiodinated arylaliphatic ether analogues of cholesterol
WO1995013096A1 (en) * 1993-11-08 1995-05-18 Peptide Delivery Systems Pty. Ltd. Labelled diagnostic compositions and methods of their use

Also Published As

Publication number Publication date
WO1999024079A1 (en) 1999-05-20

Similar Documents

Publication Publication Date Title
AU4038797A (en) Diagnostic compositions and devices utilizing same
AU6079598A (en) Additive preparation and method of use thereof
MX192025B (en) Cosmetic composition, preparation and application of same
AU3850395A (en) Hemorrhoidal compositions and method of use
PL341566A1 (en) Oral composition of yttraconasole preparation and method of obtaining same
AU5699799A (en) Makeup compositions and methods of making same
AU1532297A (en) Starch-emulsifier composition and methods of making
EP0728019A4 (en) Labelled diagnostic compositions and methods of their use
AU4266596A (en) Composition and use
AU3816697A (en) Conservin compositions and therapeutic and diagnostic uses therefor
AU4108097A (en) Microballoons-containing composition of polydimethylsiloxane
AU2630295A (en) 2-acylaminopropanol compound and medical composition
ZA961948B (en) 6-aryl pyrazoloÚ3,4-d¾pyrimidin-4-ones and compositions and methods of use thereof
AU6184396A (en) Solid oral diagnostic test meal and methods of use thereof
EP0934427A4 (en) Rh blood group antigen compositions and methods of use
AU7290898A (en) Preparation of fagopyritols and uses therefor
AU9301998A (en) Composition and methods using galectin-1
AU4006695A (en) Calcineurin interacting protein compositions and methods
AU2165497A (en) Insecticidal composition and method of preparation
AU3118297A (en) Sok-1 and methods of use
AU8898198A (en) Methods of identifying biological agent compositions
AU1841195A (en) 1-beta -methyl-carbapenem, compositions containing same and methods of use
AU6412599A (en) Oxybutynin formulations and methods of use
AU3966895A (en) Methods and compositions for the diagnosis of flea allergies
AU1856297A (en) Lyst1 and lyst2 gene compositions and methods of use